Qualigen therapeutics provides corporate update for third quarter and to date 2023

Carlsbad, calif., nov. 14, 2023 (globe newswire) -- qualigen therapeutics, inc. (nasdaq: qlgn), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for orphan drug designation, today provides a corporate update for the third quarter ending september 30, 2023 and to date:
QLGN Ratings Summary
QLGN Quant Ranking